Health Care Innovation

Commentary

Candidates can’t afford silence on health care

Democrats and Republicans are further apart than they’ve been in half a century, according to the Pew Research Center. But nearly 4 in 10 tell pollsters that they’d be open to supporting a candidate from a different political party whose top priority was reducing health care costs. Many Democrats have ...
Commentary

House’s New Healthcare Reform Drags Medical Pricing to Sunlight

One of the most glaring deficiencies in America’s healthcare system is its lack of price transparency. For too long, the bottom-line price of everything from prescription drugs to MRI scans and in-patient medical procedures has remained a mystery to most consumers. This is no accident. By obscuring this information, providers, ...
Featured

Sally Pipes featured in New York Post regarding undocumented immigrants in CA qualifying for free healthcare

By Victor Nava Cash-strapped California will ring in the new year by offering free health care to all undocumented immigrants who qualify for the state’s government-run health insurance program. “The expansion was a bad idea when the state’s coffers were flush. Now that California is struggling to make ends meet, ...
Commentary

New Report Confirms: Left’s Health Policy Is Malignant

Earlier this month, the federal Centers for Medicare and Medicaid Services (CMS) released new data on the state of U.S. health spending. The agency’s report offers a chilling diagnosis of the challenges facing the U.S. health system. It also reveals just how misguided the Democrats’ health policy agenda has been ...
Commentary

Biden Is Medical Innovation’s Executioner

President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Blog

Read how Biden plan would hurt medical innovation

The Biden Administration Abuses Inflation to Attack Medical Innovation

It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Commentary

Will Trump’s Hospital Price Transparency Rule Resurge?

One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
Commentary

The Federal Trade Commission’s Assault On Growth

The FTC’s mission is to protect consumers by ensuring that markets are competitive, not to protect competitors. Presumably, the Commissioners imagine that the theoretical harm to competitors will somehow make consumers worse off, but if this sounds far-fetched, this is precisely what an FTC administrative judge concluded when hearing the ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Commentary

Government Regulation Threatens Life-Saving Innovation

Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.

New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Commentary

Candidates can’t afford silence on health care

Democrats and Republicans are further apart than they’ve been in half a century, according to the Pew Research Center. But nearly 4 in 10 tell pollsters that they’d be open to supporting a candidate from a different political party whose top priority was reducing health care costs. Many Democrats have ...
Commentary

House’s New Healthcare Reform Drags Medical Pricing to Sunlight

One of the most glaring deficiencies in America’s healthcare system is its lack of price transparency. For too long, the bottom-line price of everything from prescription drugs to MRI scans and in-patient medical procedures has remained a mystery to most consumers. This is no accident. By obscuring this information, providers, ...
Featured

Sally Pipes featured in New York Post regarding undocumented immigrants in CA qualifying for free healthcare

By Victor Nava Cash-strapped California will ring in the new year by offering free health care to all undocumented immigrants who qualify for the state’s government-run health insurance program. “The expansion was a bad idea when the state’s coffers were flush. Now that California is struggling to make ends meet, ...
Commentary

New Report Confirms: Left’s Health Policy Is Malignant

Earlier this month, the federal Centers for Medicare and Medicaid Services (CMS) released new data on the state of U.S. health spending. The agency’s report offers a chilling diagnosis of the challenges facing the U.S. health system. It also reveals just how misguided the Democrats’ health policy agenda has been ...
Commentary

Biden Is Medical Innovation’s Executioner

President Joe Biden just declared war on medical science — and has undermined his “Cancer Moonshot.” That’s the only way to interpret the administration’s announcement last week arrogating the power to seize patents for medicines and other technologies developed with taxpayer funds on the grounds that they’re too expensive. The president claims ...
Blog

Read how Biden plan would hurt medical innovation

The Biden Administration Abuses Inflation to Attack Medical Innovation

It is theoretically bankrupt because price changes for individual goods and services reflect unique market factors in addition to broad-based inflation trends. There is no reason to expect any good’s price changes to always equal the average of all price changes (e.g., measured inflation). For instance, a deep frost that ...
Commentary

Will Trump’s Hospital Price Transparency Rule Resurge?

One of President Donald J. Trump’s greatest health-policy coups during his term in office came in 2019. His executive order directed hospitals to disclose the prices of a range of services and treatments. The logic behind the order was straightforward. In order for healthcare markets to function efficiently, patients need ready access ...
Commentary

The Federal Trade Commission’s Assault On Growth

The FTC’s mission is to protect consumers by ensuring that markets are competitive, not to protect competitors. Presumably, the Commissioners imagine that the theoretical harm to competitors will somehow make consumers worse off, but if this sounds far-fetched, this is precisely what an FTC administrative judge concluded when hearing the ...
Commentary

Drug price controls hurt patients

Costly Imported Medicines Leave Patients Vulnerable

Texas just became the latest state to look north for lower drug prices. As of the beginning of this month, the state’s Health and Human Services Commission gained authority to contract with Canadian wholesalers and suppliers to import prescription drugs from our northern neighbor. The prices of brand-name prescription drugs ...
Commentary

Government Regulation Threatens Life-Saving Innovation

Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.

New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Scroll to Top